Boris Rudic
Overview
Explore the profile of Boris Rudic including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
75
Citations
764
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Krug D, Zaman A, Eidinger L, Grehn M, Boda-Heggemann J, Rudic B, et al.
Strahlenther Onkol
. 2023 Jun;
199(7):621-630.
PMID: 37285038
Background: Single-session cardiac stereotactic radiation therapy (SBRT) has demonstrated promising results for patients with refractory ventricular tachycardia (VT). However, the full safety profile of this novel treatment remains unknown and...
12.
Grehn M, Mandija S, Miszczyk M, Krug D, Tomasik B, Stickney K, et al.
Europace
. 2023 Mar;
25(4):1284-1295.
PMID: 36879464
The EU Horizon 2020 Framework-funded Standardized Treatment and Outcome Platform for Stereotactic Therapy Of Re-entrant tachycardia by a Multidisciplinary (STOPSTORM) consortium has been established as a large research network for...
13.
Christiansen M, Kjaer-Sorensen K, Clavsen N, Dittmann S, Jensen M, Guldbrandsen H, et al.
Heart Rhythm
. 2023 Feb;
20(8):1136-1143.
PMID: 36806574
Background: A variant in the SLC4A3 anion exchanger has been identified as a novel cause of short QT syndrome (SQTS), but the clinical importance of SLC4A3 as a cause of...
14.
Mayinger M, Boda-Heggemann J, Mehrhof F, Krug D, Hohmann S, Xie J, et al.
Phys Imaging Radiat Oncol
. 2023 Jan;
25:100406.
PMID: 36655216
A novel quality assurance process for electroanatomical mapping (EAM)-to-radiotherapy planning imaging (RTPI) target transport was assessed within the multi-center multi-platform framework of the RAdiosurgery for VENtricular TAchycardia (RAVENTA) trial. A...
15.
Ansari U, Overhoff D, Burkhoff D, Fastner C, Yucel G, Roger S, et al.
Sci Rep
. 2022 Nov;
12(1):20504.
PMID: 36443407
We hypothesized that myocardial septal scarring, assessed by cardiac magnetic resonance (CMR) using late gadolinium enhancement (LGE), at the site of cardiac contractility modulation (CCM) lead placement may predict treatment...
16.
Fastner C, Yuecel G, Hetjens S, Rudic B, Schmiel G, Toepel M, et al.
Clin Res Cardiol
. 2022 Sep;
111(11):1286-1294.
PMID: 36056955
Background: Cardiac contractility modulation (CCM) is an FDA-approved device therapy for patients with refractory systolic heart failure and normal QRS width. Randomized trials demonstrated benefits of CCM primarily for patients...
17.
Kluge A, Ehrbar S, Grehn M, Fleckenstein J, Baus W, Siebert F, et al.
Int J Radiat Oncol Biol Phys
. 2022 Jun;
114(2):360-372.
PMID: 35716847
Purpose: Cardiac radioablation is a novel treatment option for patients with refractory ventricular tachycardia unsuitable for catheter ablation. The quality of treatment planning depends on dose specifications, platform capabilities, and...
18.
Barc J, Tadros R, Glinge C, Chiang D, Jouni M, Simonet F, et al.
Nat Genet
. 2022 Apr;
54(5):735.
PMID: 35474365
No abstract available.
19.
Gauter-Fleckenstein B, Tulumen E, Rudic B, Borggrefe M, Polednik M, Fleckenstein J
Strahlenther Onkol
. 2022 Mar;
198(6):566-572.
PMID: 35267050
Purpose: In the beam penumbra of stereotactic body radiotherapy volumes, dose rate effects in implantable cardioverter-defibrillators (ICDs) may be the predominant cause for failures in the absence of neutron-generating photon...
20.
Yucel G, Fastner C, Hetjens S, Toepel M, Schmiel G, Yazdani B, et al.
Pacing Clin Electrophysiol
. 2022 Mar;
45(5):639-648.
PMID: 35262210
Background: Cardiac contractility modulation (CCM), being reserved for patients with symptomatic chronic heart failure (HF) and narrow QRS complex under guideline directed medical therapy, can recover initially reduced left ventricular...